Omead Afshar, known for his ability to mind-meld with the CEO, steps into the prominent role as the auto business confronts ...

After graduating, he joined the medical-device company St. Jude Medical, which was later acquired by Abbott Laboratories. Omead Afshar once ran Tesla’s office of the CEO and oversaw construction of ...

The world’s biggest bond market climbed after the latest jobs report bolstered speculation the Federal ... Its current run rate is $230 million. Abbott Laboratories shares rose nearly 5 per cent ...

A Californian who joined Tesla seven years ago, Afshar once ran Tesla’s office of the CEO and oversaw construction of Tesla’s ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions and product launches strengthen the company's market presence.

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

In the last three months, 15 analysts have published ratings on Abbott Laboratories (NYSE:ABT), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their ...

So on that note, Abbott Laboratories (NYSE:ABT) looks quite promising in regards to its trends of return on capital. What Is Return On Capital Employed (ROCE)? Just to clarify if you're unsure ...

Nov 1 (Reuters) - Abbott Laboratories (ABT.N), opens new tab shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over ...

A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...